Patients treated with natural (leukocyte-derived) interferon (IFN)-alpha do not develop IFN antibodies.
A
A
Osterborg
K
K
Engman
M
M
Björeman
K
K
Carlson
E
E
Kimby
M
M
Ohrling
J
J
Samuelsson
E
E
Osby
H
H
Mellstedt
D000906:Antibodies / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*; D011994:Recombinant Proteins
D000906:Antibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins